 Sal B treatment has neuroprotective and antiepileptic effects against a PTZ-induced seizure rat model.  The effects of Sal B may be attributed to the activation of Akt / CREB / BDNF signaling pathways and inhibition of neuronal apoptosis.
Introduction
Epilepsy is a common chronic neurological disorder that affects 50 to 70 million individuals, accounting for 0.75% of the global disease burden [1] . Although, there are a myriad of antiepileptic drugs (AEDs) available, approximately one third of epileptic patients fail to achieve complete remission from the occurrence of seizures [2] . In addition, some patients suffer from serious side-effects when receiving AED treatment, such as paraesthesia, teratogenicity, agranulocytosis and glaucoma [3] .
Therefore, the development of novel antiepileptic agents that suppress the epileptic process effectively and safely is urgently required.
The genes of the B-cell lymphoma-2 (Bcl-2) family encode various proteins that positively (pro-apoptotic proteins, such as Bax and Bad) or negatively (anti-apoptotic proteins, such as Bcl-2) regulate cytochrome c release and caspase activation [4, 5] . In the early 1990s, Gillardon et al. identified a decrease of approximately 45% in the intensity of Bcl-2 immunoreactivity and an increase of nearly 3-fold in Bax levels in the brains of kainate-treated mice [6] . An increasing number of researchers have subsequently focused their attention on the relationship between epilepsy and neuronal apoptosis, with studies demonstrating that neuronal apoptosis might be a cause or consequence of epilepsy, possibly offering alternative potential targets for A C C E P T E D M A N U S C R I P T epilepsy treatment [7, 8] . Moreover, accumulating evidence has indicated that protein kinase B (AKT) is able to activate the cAMP response element binding protein (CREB) and thereby induce the transcription of target genes, such as brain-derived neurotrophic factor (Bdnf), which promotes neuronal survival by inhibiting neuronal apoptosis [9] [10] [11] . Thus, activation of the AKT/CREB/BDNF signaling pathways appears to be a promising strategy to inhibit neuronal apoptosis in order to suppress epilepsy.
Salvianolic acid B (Sal B), a major, water-soluble component of the Chinese herb Danshen, displays beneficial effects in neurological disorders, such as vascular dementia [12] , cerebral ischemia / reperfusion injury [13] , Alzheimer's disease [14] , ischemic stroke [15] and traumatic brain injury [16] . In addition, it has been shown to inhibit apoptosis in non-tumor cells, such as cardiomyocytes [17] , Schwann cells [18] and hepatocytes [19] , and also induce apoptosis in tumor cells, such as ovarian cancer cells [20] , retinoblastoma cells [21] and glioma cells [22] . Nevertheless, whether Sal B displays beneficial effects in epilepsy through regulation of apoptosis remains unknown. Therefore, this study aimed to determine the anticonvulsant and neuroprotective effects of Sal B in pentylenetetrazole (PTZ)-kindled rats via regulation of the AKT/CREB/BDNF signaling pathways and whether these effects would cause a reduction in neuronal apoptosis.
Materials and methods

Animals
60 adult male Sprague-Dawley rats, weighting 230 ± 20 g were housed in
standard conditions of temperature and humidity with a 12-hour light-dark cycle. All animals were provided ad libitum access to food and water. All procedures were approved by the guidelines of the Animal Care and Use Committee at the Second Affiliated Hospital of Jiaxing University. Animals were randomly divided into a control group (n=20), a 'PTZ' group (n=20) and a 'PTZ + Sal B' group (n=20).
PTZ-induced seizures
PTZ (Sigma-Aldrich; St. Louis, MO, USA) was diluted in saline and used to induce seizures as described in a previous study [23] . Briefly, a sub-convulsive dose 
Biological Products; Beijing, China) once a day for 29 days. Twenty four hours after the last injection of PTZ, all animals were sacrificed while under anesthesia through i.p. injection of 3.5% chloral hydrate (10 ml/kg). Brains were retrieved from the animals and the cortical and hippocampal tissues separated. Samples were stored at -80℃ for Western blotting analysis (control (n=10), 'PTZ' (n=8) and 'PTZ + Sal B' (n=10) groups) and as 10-μm frozen sections at -80℃ for immunofluorescence (IF) and terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) staining (control (n=10), 'PTZ' (n=8) and 'PTZ + Sal B' (n=9) groups).
Evaluation of neural density
Microtubule-associated protein 2 (MAP2), a neural marker, was used to identify neurons by IF staining in order to evaluate neuronal density in the cortices and hippocampi. Briefly, after blocking with 10% goat serum, brain sections were incubated with a rabbit MAP2 antibody (1:100, Abcam; San Francisco, CA, USA) at 4℃ overnight. On the following day, sections were washed three times with phosphate buffered saline (PBS) and incubated with a goat rabbit IgG heavy and light chain (H&L) antibody (FITC, 1:100, Abcam) at 4℃ for 30 minutes. After washing three times with PBS, the sections were incubated for 5 minutes with 4′, 6-diamidino-2-phenylindole (DAPI) to stain the cell nuclei. Laser scanning confocal microscopy (Olympus IX71) was used to obtain images of sections. The number of MAP2-positive cells was calculated using ImageJ software.
TUNEL staining
A TUNEL staining kit (Boster Biological Engineering Co. Ltd; Wuhan, China)
was used to determine the degree of cell apoptosis, in accordance with the manufacturer's instructions. Sections were stained for MAP2 protein in neurons, with cell nuclei stained with DAPI. A total of 3 individual fields of each section were randomly observed in both the CA1 and cortex regions using a laser scanning confocal microscope (Olympus IX71). ImageJ software was used to calculate the ratio of TUNEL and MAP2-positive cells (neuronal apoptosis rate).
Western blotting
After mincing the tissue with dissecting scissors on ice, the cortical and 
Statistical analysis
All data are presented as means ± standard deviation after analysis by researchers blind to the experimental conditions, using SPSS 16.0 statistical software (IBM; Armonk, NY, USA). Significance between groups was ascertained using one-way analysis of variance (ANOVA) followed by a post hoc Tukey's test for multiple-group comparisons. Differences with a p value < 0.05 were considered statistically significant.
Results
Effects of Sal B on PTZ-induced seizures
After 15 PTZ injections, four animals in the 'PTZ' group and one in the 'PTZ + Sal B' group died due to serious generalized clonic-tonic seizures. However, no animals died in the control group. The incidence of full kindling was 90% and 55% in the 'PTZ' and 'PTZ + Sal B' groups, respectively. We analyzed the seizure score, 
Effects of Sal B on neuronal density in rats in which seizure was induced by PTZ
The number of neurons in the cortices decreased significantly in the 'PTZ' group compared with the control group. However, Sal B treatment caused a significant increase in neuronal density in the cortices compared with rats that had received only saline injections ( Fig. 2A, PTZ 
Effects of Sal B treatment on neuronal apoptosis in rats with PTZ-induced seizure
In order to detect whether Sal B treatment was able to suppress neuronal apoptosis, IF staining of DAPI/TUNEL/MAP2 was performed and the neuronal apoptosis rate calculated. The rate of neuronal apoptosis in the cortices increased significantly in the 'PTZ' group compared with that in the control group and decreased significantly in the 'PTZ + Sal B' group compared with the 'PTZ' group (Fig. 4A, PTZ 
Effects of Sal B on AKT/CREB/BDNF signaling in rats in which seizure was induced by PTZ
Finally, we also measured the expression of BDNF and phosphoinositide 3-kinase (PI3K) pathway-related proteins, namely AKT and CREB. In both the cortices (Fig. 6A) and hippocampi (Fig. 6B) , a significant decrease in the expression levels of p-AKT (Fig. 6A, PTZ vs control, p<0.0001 ; PTZ + Sal B vs PTZ, p<0.0001; (Fig. 6B, PTZ (Fig. 6B, PTZ vs (Fig. 6B, PTZ vs control, p<0.0001 ; PTZ + Sal B vs PTZ, p<0.0001; F (2, 25)=28.68, p<0.0001) was detected in the 'PTZ' group compared with the control group. In contrast, the expression levels of p-AKT, p-CREB and BDNF in the 'PTZ + Sal B' group were significantly higher than in the 'PTZ' group.
Discussion
In the present study, we found that the severity index, which determines the intensity of seizures, of PTZ-kindled rats treated with Sal B was lower than rats without Sal B treatment. Importantly, Sal B treatment suppressed neural loss through inhibition of neuronal apoptosis. Moreover, we also demonstrated that Sal B treatment activated the AKT/CREB/BDNF signaling pathway. Thus, we conclude that Sal B exhibits anticonvulsant and anti-apoptotic effects through activation of the AKT/CREB/BDNF signaling pathway in PTZ-kindled rats.
Seizure-induced neuronal apoptosis is a well-established phenomenon that occurs in the cortices and hippocampi of patients with epilepsy and experimental seizure animal models [7] . Furthermore, the balance between the pro-apoptotic protein Bax and anti-apoptotic protein Bcl-2 is closely related to the release of cytochrome c from the mitochondria, which inhibits activation of caspase-9 and A C C E P T E D M A N U S C R I P T caspase-3 protease enzymes that mediate programmed cell death [4, 5] . In this research study, we clearly detected neuronal apoptosis in the cortices and hippocampi of rats that received 15 PTZ injections, accompanied by the down-regulation of Bcl-2 and up-regulation of Bax and cleaved caspase-3, which is in agreement with a previous research study [ Nevertheless, our findings provide a novel intervention strategy for human epilepsy.
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